Genome Company

Genome Company

Innovative biologics for global healthcare, pioneering treatments beyond existing medicines.

HQ location
Seongnam-si, South Korea
Launch date
Employees
Enterprise value
$306—459m
Company register number
6278700257
Recent deals
  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor

€0.0

round
investor

€0.0

round
N/A

€0.0

round
investor investor investor investor

€0.0

round
investor investor investor investor

€0.0

round
N/A

KRW91.3b

Late VC
Total Funding000k
Notes (0)
More about Genome Company
Made with AI
Edit

Genome Company is a biotechnology firm specializing in the development of innovative biologics aimed at addressing unmet medical needs. Operating in the global healthcare market, the company focuses on creating new treatment possibilities that go beyond traditional medicines. Genome Company serves a diverse range of clients, including healthcare providers, research institutions, and pharmaceutical companies. The business model revolves around the research, development, and commercialization of novel biologics, generating revenue through product sales, licensing agreements, and partnerships. The company's pipeline includes a variety of promising candidates such as GEN 001, SB 121, and GEN 501, which target different therapeutic areas. By adhering to core values of brave innovation and growth for all, Genome Company aspires to make a positive impact on global health.

Keywords: biotechnology, biologics, healthcare, innovation, research, development, commercialization, partnerships, therapeutic, global health.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Investments by Genome Company

Edit